PECCATORI NICOLO'

Peccatori, N., Di Majo, B., Claut, L., Colombini, A., Gotti, G., Leoni, V., et al. (2025). First-Line Postremission Blinatumomab as Successful Toxicity-Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia. PEDIATRIC BLOOD & CANCER, 72(9) [10.1002/pbc.31887]. Dettaglio

Di Majo, B., Peccatori, N., Inzoli, A., Degrate, L., Jaconi, M., Ratti, M., et al. (2025). Case Report: Post-splenectomy bulky pelvic splenosis in an adolescent with hereditary spherocytosis. FRONTIERS IN PEDIATRICS, 13 [10.3389/fped.2025.1581533]. Dettaglio

Peccatori, N., Brivio, E., Lissat, A., Bautista Sirvent, F., Salzer, E., Biondi, A., et al. (2025). Molecularly Targeted Small Molecule Inhibitor Therapy for Pediatric Acute Lymphoblastic Leukemia: A Comprehensive Review of Clinical Trials. CANCERS, 17(20) [10.3390/cancers17203322]. Dettaglio

Peccatori, N., Coppola, M., Colombini, A., Silvestri, D., Bertorello, N., Kiren, V., et al. (2025). Eight-year national multicenter experience on the use of glucarpidase as effective rescue therapy for delayed methotrexate elimination after high-dose methotrexate cycles administered in children with hemato-oncological diseases. EJC PAEDIATRIC ONCOLOGY, 5(June 2025) [10.1016/j.ejcped.2024.100202]. Dettaglio

Peccatori, N., Ardissino, G., Cesaro, S., Danesi, R., Gaspari, S., Meazza, C., et al. (2025). Italian expert consensus recommendations for the safe administration of high-dose methotrexate in children with cancer and for the use of glucarpidase to manage delayed methotrexate elimination and/or high-dose methotrexate-induced acute kidney injury. CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 73(4 (December 2025)) [10.1016/j.retram.2025.103551]. Dettaglio